Vol 5 Issue 12

CELL AND GENE THERAPY INSIGHTS

December 2019 Issue

Vol 5 Issue 12

Download PDF

Featuring

Issue Spotlight: 2020 Vision: Trends & Technologies of Tomorrow
Materials Collection & Logistics at the Clinical Point of Care 2019
Other articles
Webinars

SPOTLIGHT

2020 Vision: Trends & Technologies of Tomorrow

Perspective

Clinical development of ATMPs: hospitals as an exemption?

Clinical development of ATMPs: hospitals as an exemption?

Martin Hildebrandt
29 November 2019
Read
Vision 2020: what could come about in the next decade for biotech?

Vision 2020: what could come about in the next decade for biotech?

Michael Yee
29 November 2019
Read
New frontiers: cellular immunotherapy beyond cancer

New frontiers: cellular immunotherapy beyond cancer

Matthew Brook, Joanna Hester, Fadi Issa
26 November 2019
Read

Innovator Insight

Automation in cell and gene bioprocessing: challenges, opportunities and what lies ahead

Automation in cell and gene bioprocessing: challenges, opportunities and what lies ahead

Frank Corbin
27 January 2020
Read

Interview

Introducing flexibility to automation to unleash the power of biology

Introducing flexibility to automation to unleash the power of biology

Markus Gershater
3 February 2020
Read
Analyzing key ATMP talking points through IP and regulatory lenses

Analyzing key ATMP talking points through IP and regulatory lenses

Beatriz San Martin, Jackie Mulryne
19 December 2019
Read
Advancing iPSC-derived NK cell therapy

Advancing iPSC-derived NK cell therapy

Bahram Valamehr
19 December 2019
Read
Oncology and beyond: looking to the future of CAR-T and autologous cell therapy

Oncology and beyond: looking to the future of CAR-T and autologous cell therapy

Stephan Grupp
18 December 2019
Read
Bioprocess decisional tools to enable cell and gene therapy commercialization

Bioprocess decisional tools to enable cell and gene therapy commercialization

Suzanne Farid
11 December 2019
Read
Brave new world – a new decade in allogeneic cellular immunotherapy

Brave new world – a new decade in allogeneic cellular immunotherapy

David Sourdive
29 November 2019
Read
Where will synthetic biology take cell & gene therapy?

Where will synthetic biology take cell & gene therapy?

Timothy Lu
28 November 2019
Read
Next steps for the iPSC and tissue engineering fields

Next steps for the iPSC and tissue engineering fields

Ioannis Papantoniou
25 November 2019
Read
Regulatory insights and lessons learned for a new decade in cell & gene therapy

Regulatory insights and lessons learned for a new decade in cell & gene therapy

Joyce L Frey-Vasconcells
20 November 2019
Read

Podcast

Introducing flexibility to automation to unleash the power of biology – Podcast

Introducing flexibility to automation to unleash the power of biology – Podcast

Markus Gershater
10 February 2020
Listen

Expert Roundtable Video

Expert Roundtable: Scale-up considerations for improved yield in upstream viral vector production

Expert Roundtable: Scale-up considerations for improved yield in upstream viral vector production

S Ansorge, M Burnham, M Kelly et al.
17 February 2020
Watch

Expert Roundtable

Scale-up considerations for improved yield in upstream viral vector production

Scale-up considerations for improved yield in upstream viral vector production

S Ansorge, M Burnham, M Kelly et al.
5 February 2020
Read

Supply Chain FOCUS

Materials Collection & Logistics at the Clinical Point of Care 2019

Foreword

Managing starting materials collection and logistics at the clinical point of care

Managing starting materials collection and logistics at the clinical point of care

John DM Campbell
5 December 2019
Read

Expert Insight

Cell and tissue starting materials for ATMPs

Cell and tissue starting materials for ATMPs

Neil W McGowan, John DM Campbell, Joanne C Mountford
5 December 2019
Read
Challenges in the procurement of starting materials for ATMP manufacture

Challenges in the procurement of starting materials for ATMP manufacture

S Zahra, L Manson, L Jarvis et al.
4 December 2019
Read

Interview

Evolving the supply chain to counter key challenges in apheresis and leukapheresis collection

Evolving the supply chain to counter key challenges in apheresis and leukapheresis collection

Peter Olagunju
4 December 2019
Read

Journal articles

Expert Insight

Performance of in-house optimized orthogonal methods for titration of in-process and purified rAAV

Performance of in-house optimized orthogonal methods for titration of in-process and purified rAAV

Franz Schnetzinger, Kamila Pytel, Helena Pudilova
22 November 2019
Read

Interview

Emerging tools and needs for AAV vector characterisation

Emerging tools and needs for AAV vector characterisation

Fabien Dorange
22 November 2019
Read

Commercial Insights

Cell & Gene Therapy Commercial Insight – November 2019

Cell & Gene Therapy Commercial Insight – November 2019

Mark Curtis, Richard Philipson
23 December 2019
Read

Webinars